Associated Papers
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.
Wang M et al.
Nature Communications, 2015
26443449 (PubMed )
Supplement: ncomms9469-s1.pdf
Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.
Lim AM et al.
International Journal of Cancer, 2014
Genetic susceptibility in familial melanoma from northeastern Italy.
Landi MT et al.
Journal of Medical Genetics, 2004
CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
Holland EA et al.
Genes, Chromosomes & Cancer, 1999
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA et al.
British Journal of Cancer, 1999
CDKN2A variants in a population-based sample of Queensland families with melanoma.
Aitken J et al.
Journal of the National Cancer Institute, 1999
Stability and folding of the tumour suppressor protein p16.
Tang KS et al.
Journal of Molecular Biology, 1999
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Soufir N et al.
Human Molecular Genetics, 1998
The CDKN2A (p16) gene and human cancer.
Foulkes WD et al.
Molecular Medicine (cambridge, Mass.), 1997
Select a paper to view details